Labiotech.eu - Europe's leading Biotech News Website

Latest Posts

maat pharma autologous microbiome therapy

News and Trends 23 Mar 2016

French Microbiome Startup Gets €10M to Start Clinical Trials

MaaT Pharma (France) has raised €10M in a series A round, which will allow it to start clinical development of its autologous therapy for imbalance of the Gut Microbiome. MaaT Pharma is developing microbiome-based therapies with an autologous (self-sourced) approach. This means that the patient suffering from dysbiosis is treated with their own microbiome, samples of which were […]

March 23, 2016 - 3 minutesmins - By Denise Neves Gameiro

evotec topas therapeutics autoimmune nanotechnology

News and Trends 23 Mar 2016

Leading German Biotech Spins Off a New Startup in Autoimmune Diseases

Evotec (Germany) has launched a spin-off, Topas Therapeutics, to create nanoparticle-based therapeutics to treat immunological disorders. After starting a collaboration for microbiome-related diseases and entering the immuno-oncology field, Evotec is creating a spin-off dedicated to autoimmune diseases. This new biotech, Topas Therapeutics, is based on a technology that induces liver tolerance to specific antigens. This platform could be used to create breakthrough therapies for […]

March 23, 2016 - 2 minutesmins - By Denise Neves Gameiro

hiv virus vaccine la provence retroviral biosahntech anrs

News and Trends 23 Mar 2016

No, this French Startup didn’t Discover the Cure for HIV…

This is the story of a French doctor and his start-ups which have been trying to develop a cure for HIV for the last 10 years. The problem resides in exaggerating, not publishing data…and then repeating this process again and again. Last week, the professor Erwann Loret and his start-up Biosantech did a press conference to announce new “breakthrough” […]

March 23, 2016 - 3 minutesmins - By Philip Hemme

metrion drug discovery cardiac risk eurostars

News and Trends 22 Mar 2016

Eurostars grants Metrion €2.2M for Novel Drug Discovery Tests

Metrion Biosciences (UK) is receiving €2.2M in funding for its project to develop phenotypic cardiac safety assays, that could make drug discovery cheaper and faster. Metrion is a Contract Research Organization out of the Babraham Institute in Cambridge (one of the 10 hottest bioincubators in Europe). It provides screening services for drugs still in the discovery […]

March 22, 2016 - 3 minutesmins - By Denise Neves Gameiro

bento lab philipp boeing kickstarter diy bio biohacking ucl igem

News and Trends 22 Mar 2016

The ‘Lunch Box’ sized Laboratory for Biohackers, Educators and Artists

Bento Bio is a London SynBio start-up founded around the Bento Lab; designed to include all the major components needed for a field laboratory, but with a sleek (and frankly, very good looking) interface. I met Philipp Boeing at a ‘Digital Biology’ (Do-it-yourself) meet-up in Berlin a couple months back, where the biohacking community would come […]

March 22, 2016 - 7 minutesmins - By Dani Bancroft

russia biotech hepatera maxwell mya hepatits b d phase ii b trials

News and Trends 22 Mar 2016

Biotech in Russia: Money and a New trial for Hepatitis

The Biotech MYR Pharma (Germany) is launching German-Russian phase IIb trials for chronic hepatitis B & D infections in partnership with Moscow’s Hepatera (Russia). MYR was founded in 2010 and is based in Burgwedel, Germany, supported by investors Maxwell Biotech and High-Tech Gründerfonds (HTGF). Hepatera, on the other hand, is actually the first Russian biotech we’ve encountered […]

March 22, 2016 - 2 minutesmins - By Dani Bancroft

ADVERTISEMENT

top 5 eastern europe biotech selvita sotio solvo axon asper

News and Trends 22 Mar 2016

5 Cool Biotechs in Eastern Europe

Eastern Europe is home to fascinating culture and rising economies, but how is the Biotech scene developing there? Here are some of the companies that caught our eye. Due to popular demand, we have updated the Labiotech Map to also include Eastern European Biotechs – which we published just last month. We were not sure what we were […]

March 22, 2016 - 3 minutesmins - By Denise Neves Gameiro

indiebio 2016 startup biotech synbio

News and Trends 21 Mar 2016

Ferment the Next Bio-Revolution with IndieBio Accelerator

IndieBio is an accelerator program for new ideas in Synthetic Biology – to transform them into startups during a Summer in Ireland. The potential of Synthetic Biology ranges from biofuels to perfumes to healthcare – and it will be at the forefront of the biotechnological revolution. The concept is already implemented by big Biotechs (with a big presence in France) […]

March 21, 2016 - 2 minutesmins - By Denise Neves Gameiro

schacht curetis labiotech

News and Trends 21 Mar 2016

This CEO was responsible for the Only German Biotech IPO in 2015…

Whilst at the Sachs conference last week, I had the chance to meet with Oliver Schacht, the CEO of Curetis. It’s the only German Biotech which went public last year and this was a good enough reason to have a chat (the company is also really interesting, obviously). Curetis is based in Stuttgart in the […]

March 21, 2016 - 1 minutemin - By Philip Hemme

autolus ucl car t series b fundraising

News and Trends 21 Mar 2016

CAR-T Startup Gets €51M from Top&New Investors

Autolus (UK) has secured over €51M in a recent series B round, led by the biggest Biotech VC in Europe – and a new player in life science investment. Autolus is a 1-year-old spin-off of the University College London (UCL) focusing on the development of next-generation CAR-T therapies, addressing current limitations of this ‘wonder therapy‘. […]

March 21, 2016 - 2 minutesmins - By Denise Neves Gameiro

gapsummit full

News and Trends 18 Mar 2016

ITW: GapSummit, the Event for the European Bio-leaders of Tomorrow

Where can you meet the next generation of European Biotech leaders in one single event? For sure at GapSummit 2016, which will be held next April 4th to 6th in Cambridge, UK. We had a chat with the young Director and President of the event, Lisa Altmann-Richer, to have more details. Could you first present Global Biotech […]

March 18, 2016 - 3 minutesmins - By Philip Hemme

roche immuno oncology blueprint medicines boston

News and Trends 18 Mar 2016

Roche signs a €900M deal with an Immunotherapy Biotech in Boston

Roche (Switzerland) has picked 5 candidates from Blueprint Medicines (US) to complement its leading oncology pipeline. Roche is a leader in cancer therapies, but its position is threatened by intense competition, not to mention its stakes in the biosimilar war and some bad results from advanced trials. However, it seems that this Big Pharma still […]

March 18, 2016 - 3 minutesmins - By Denise Neves Gameiro

ADVERTISEMENT